Adjuvant Holdings Co (TSE:4929) Beta: 0.1638 (As of Jun. 29, 2026)


TSE:4929 Adjuvant Holdings Co Ltd TSE:4929
66 GF Score
Price 円717.00
GF Value 円736.83
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Adjuvant Holdings Co Beta?

Adjuvant Holdings Co TSE:4929 66 Beta is 0.1638 as of Jun. 29, 2026. GuruFocus rates TSE:4929 with a GF Score™ of 66/100 and a GF Value™ of 円736.83 (Fairly Valued). The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-29), Adjuvant Holdings Co's Beta is 0.1638.


Adjuvant Holdings Co  (TSE:4929) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Adjuvant Holdings Co Beta Related Terms


Adjuvant Holdings Co Beta Historical Data

* Premium members only.

The historical data trend for Adjuvant Holdings Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adjuvant Holdings Co Beta Chart

Adjuvant Holdings Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.31 0.23 0.17 0.20

Adjuvant Holdings Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.28 0.17 0.11 0.20

TSE:4929 vs PG, CL, KVUE: Beta Comparison

For the Household & Personal Products subindustry, Adjuvant Holdings Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adjuvant Holdings Co Beta vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Adjuvant Holdings Co's Beta distribution charts can be found below:

* The bar in red indicates where Adjuvant Holdings Co's Beta falls into.


TSE:4929
66GF Score
Adjuvant Holdings Co Ltd TSE:4929
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adjuvant Holdings Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.1638 mean?
Adjuvant Holdings Co (TSE:4929) has a Beta of 0.1638 as of Jun. 29, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Adjuvant Holdings Co and its competitors.
Is Adjuvant Holdings Co's Beta too high?
Adjuvant Holdings Co's current Beta is 0.1638. Overall, Adjuvant Holdings Co has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Adjuvant Holdings Co's Beta compare to PG and CL?
Adjuvant Holdings Co's Beta of 0.1638 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Consumer Packaged Goods company?
A good Beta depends on the Consumer Packaged Goods industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Adjuvant Holdings Co and its competitors. Adjuvant Holdings Co's current Beta is 0.1638. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adjuvant Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Adjuvant Holdings Co (TSE:4929) is currently considered Fairly Valued. The stock's GF Value™ is 円736.83, compared to a current price of 円717.00 — trading 2.7% below its estimated fair value. The current Beta is 0.1638. Adjuvant Holdings Co's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Adjuvant Holdings Co (TSE:4929), the current Beta is 0.1638 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adjuvant Holdings Co (TSE:4929) Overvalued in 2026?

Based on GuruFocus' analysis, Adjuvant Holdings Co stock appears to be undervalued. The current stock price of 円717.00 is trading 2.7% below its estimated GF Value™ of 円736.83. GuruFocus considers Adjuvant Holdings Co to be Fairly Valued.

Key valuation signals for TSE:4929:

  • Beta: 0.1638
  • GF Value™: 円736.83 vs. price of 円717.00 (2.7% below fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the TSE:4929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Adjuvant Holdings Co Business Description

Address 5-5-5 Shimoyamatedori, Chuo-ku, Hyogo Prefecture, Kobe City, JPN, 650-0011
Adjuvant Holdings Co Ltd, formerly Adjuvant Cosme Japan Co Ltd is engaged in the research, development, production, and sale of cosmetics in Japan. It offers skin care products, including cleansing products, facial cleansers, lotions, beauty essences, masks, moisturizing creams, makeup bases, makeup, and body care products among other products.
66GF Score

Get the complete analysis for TSE:4929

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円717.00
Price
円736.83
GF Value